Forte Biosciences, Inc.
SEC Filing List
FBRX CIK: 0001419041
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Forte Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/09/2026 | |
| 8-K | Current report filing | Forte Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/09/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Forte Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/08/2026 | |
| 4 | Statement of changes in beneficial owner... | Riley Antony A | Forte Biosciences, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Wagner Paul A. | Forte Biosciences, Inc. | 04/03/2026 | |
| 8-K | Current report filing | Forte Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/01/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Forte Biosciences, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/31/2026 | |
| SCHEDULE 13G/A | 02/17/2026 | ||||
| SCHEDULE 13G/A | Akin Gump Strauss Hauer & Feld LLP /fa | 01/29/2026 | |||
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 01/20/2026 | |||
| No record found. | |||||
| Load More | |||||
